BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 4701111)

  • 1. [Mild forms of acute alcoholic liver damage: significance and differential diagnosis].
    Linhart P; Kommerell B; Vereschild N
    Dtsch Med Wochenschr; 1973 May; 98(19):983-8. PubMed ID: 4701111
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical correlations in alcoholic patients without manifest cirrhosis.
    Bordalo O; Batista A; Geraldes J; Neto F; Mascarenhas F; Leitao N; Noronha M; Lamy J; Silva PE
    Am J Gastroenterol; 1974 May; 61(5):371-8. PubMed ID: 4835934
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical diagnosis of alcoholic fatty liver.
    Devenyi P; Rutherdale J; Sereny G; Olin JS
    Am J Gastroenterol; 1970 Dec; 54(6):597-602. PubMed ID: 5504217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute alcoholic hepatitis (fatty liver hepatitis)].
    Sohnack H
    Wien Med Wochenschr; 1972 Jul; 122(30):460-4. PubMed ID: 5065650
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.
    Reynolds TB; Peters RL; Yamada S
    N Engl J Med; 1971 Oct; 285(15):813-20. PubMed ID: 4108110
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver toxicity of laxatives. Results of exposure to phenolisatines].
    Henning H; von Braun HH; Look D; Lüders CJ; Vogel HM
    Z Gastroenterol; 1973 Mar; 11(2):75-84. PubMed ID: 4803412
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relevance of biochemistry in diagnosis and development of alcoholic liver disease (author's transl)].
    Ortmans H; Eisenberg K
    Med Klin; 1976 Feb; 71(9):380-4. PubMed ID: 3720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic liver damage due to ethionamide.
    Kuntz E; Liehr H; Pfingst W
    Ger Med Mon; 1968 Dec; 13(12):599-602. PubMed ID: 5735341
    [No Abstract]   [Full Text] [Related]  

  • 9. Alcoholic hyperlipaemia.
    Gebbie T; Prior IA
    Med J Aust; 1967 Oct; 2(17):769-72. PubMed ID: 6061028
    [No Abstract]   [Full Text] [Related]  

  • 10. Barbiturate jaundice. Report of a case due to a barbital-containing drug, with positive rechallenge to phenobarbital.
    Pagliaro L; Campesi G; Aguglia F
    Gastroenterology; 1969 May; 56(5):938-43. PubMed ID: 4238546
    [No Abstract]   [Full Text] [Related]  

  • 11. The increased mortality rate of open liver biopsy in alcoholic hepatitis.
    Greenwood SM; Leffler CT; Minkowitz S
    Surg Gynecol Obstet; 1972 Apr; 134(4):600-4. PubMed ID: 5015523
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Fontana et al.
    Collyer E; Kay M
    Am J Gastroenterol; 2016 Feb; 111(2):297. PubMed ID: 26882951
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Collyer et al.
    Fontana RJ
    Am J Gastroenterol; 2016 Feb; 111(2):297-8. PubMed ID: 26882950
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical evaluation of liver and pancreas following selective and subselective angiography.
    Goldstein HM; Bookstein JJ
    Radiology; 1974 May; 111(2):293-5. PubMed ID: 4818966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-induced liver disorders].
    Bismuth M
    Gastroenterol Clin Biol; 1999; 23(8-9):915-6. PubMed ID: 10533144
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute alcoholic hepatitis: diagnosis, treatment, prognosis.
    Thompson DK
    J Maine Med Assoc; 1973 Aug; 64(8):167-70. PubMed ID: 4732643
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of liver-RES on toxic liver damage due to galactosamine.
    Grün M; Liehr H; Grün W; Rasenack U; Brunswig D
    Acta Hepatogastroenterol (Stuttg); 1974 Feb; 21(1):5-15. PubMed ID: 4450963
    [No Abstract]   [Full Text] [Related]  

  • 19. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.
    Murata Y; Ogawa Y; Saibara T; Nishioka A; Fujiwara Y; Fukumoto M; Inomata T; Enzan H; Onishi S; Yoshida S
    Oncol Rep; 2000; 7(6):1299-304. PubMed ID: 11032933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tianeptine induced acute hepatitis].
    Macaigne G; Auriault ML; Chayette C; Cheiab S; Deplus R
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):348-9. PubMed ID: 12700528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.